Liver cell-specific peptides derived from the preS1 domain of human hepatitis B virus

Journal of Virological Methods

Volumn 201, Issue , 2014, Pages 20-23

  Kang, Jeong Hun ^a   Toita, Riki ^b   Asai, Daisuke ^c   Yamaoka, Tetsuji ^a   Murata, Masaharu ^d  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d KYUSHU UNIVERSITY   (Japan)

Author keywords

Hepatocellular carcinoma; Hepatocyte; Human hepatitis B virus; Peptide substrate; PreS1

Indexed keywords

PROTEIN PRES1; UNCLASSIFIED DRUG; VIRUS PROTEIN; HEPATITIS B SURFACE ANTIGEN; PEPTIDE; PRESURFACE PROTEIN 1, HEPATITIS B SURFACE ANTIGEN; PROTEIN BINDING; PROTEIN PRECURSOR;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CELL STRAIN HEPG2; CONTROLLED STUDY; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; MOUSE; MYRISTYLATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN TARGETING; GENETICS; LIVER CELL; METABOLISM; PROTEIN TRANSPORT; TUMOR CELL LINE;

CELL LINE, TUMOR; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATOCYTES; HUMANS; PEPTIDES; PROTEIN BINDING; PROTEIN PRECURSORS; PROTEIN TRANSPORT;

EID: 84895789111     PISSN: 01660934     EISSN: 18790984     Source Type: Journal    
DOI: 10.1016/j.jviromet.2014.02.013     Document Type: Article

References (15)

1. Bremer C.M., Sominskaya I., Skrastina D., Pumpens P., El Wahed A.A., Beutling U., Frank R., Fritz H.J., Hunsmann G., Gerlich W.H., Glebe D. N-terminal myristoylation-dependent masking of neutralizing epitopes in the preS1 attachment site of hepatitis B virus. J. Hepatol. 2011, 55:29-37.
2. Engelke M., Mills K., Seitz S., Simon P., Gripon P., Schnölzer M., Urban S. Characterization of a hepatitis B and hepatitis delta virus receptor binding site. Hepatology 2006, 43:750-760.
3. Glebe D., Urban S. Viral and cellular determinants involved in hepadnaviral entry. World J. Gastroenterol. 2007, 13:22-38.
4. Glebe D., Urban S., Knoop E.V., Çaǧ N., Krass P., Grün S., Bulavaite A., Sasnauskas K., Gerlich W.H. Mapping of the hepatitis B virus attachment site by use of infection-inhibiting preS1 lipopeptides and tupaia hepatocytes. Gastroenterology 2005, 129:234-245.
5. Gripon P., Cannie I., Urban S. Efficient inhibition of hepatitis B virus infection by acylated peptides derived from the large viral surface protein. J. Virol. 2005, 79:1613-1622.
6. Hu W.G., Wei J., Xia H.C., Yang X.X., Li F., Li G.D., Wang Y., Zhang Z.C. Identification of the immunogenic domains in HBsAg preS1 region using overlapping preS1 fragment fusion proteins. World J. Gastroenterol. 2005, 11:2088-2094.
7. Kang J.H., Oishi J., Kim J.H., Ijuin M., Toita R., Jun B., Asai D., Mori T., Niidome T., Tanizawa K., Kuroda S., Katayama Y. Hepatoma-targeted gene delivery using a tumor cell-specific gene regulation system combined with a human liver cell-specific bionanocapsule. Nanomed.: Nanotechnol. Biol. Med. 2010, 6:583-589.
8. Lee K.W., Tey B.T., Ho K.L., Tan W.S. Delivery of chimeric hepatitis B core particles into liver cells. J. Appl. Microbiol. 2012, 112:119-131.
9. Mahtab M.A., Rhman S., Khan M., Karim F. Hepatitis B virus genotypes: an overview. Hepatobiliary Pancreat. Dis. Int. 2008, 7:457-464.
10. McMahon B.J. The influence of hepatitis B virus genotype and subgenotype on the natural history of chronic hepatitis B. Hepatol. Int. 2009, 3:334-342.
11. Meier A., Mehrle S., Weiss T.S., Mier W., Urban S. Myristoylated preS1-domain of the hepatitis B virus L-protein mediates specific binding to differentiated hepatocytes. Hepatology 2013, 58:31-42.
12. Miyata R., Ueda M., Jinno H., Konno T., Ishihara K., Ando N., Kitagawa Y. Selective targeting by preS1 domain of hepatitis B surface antigen conjugated with phosphorylcholine-based amphiphilic block copolymer micelles as a biocompatible, drug delivery carrier for treatment of human hepatocellular carcinoma with paclitaxel. Int. J. Cancer 2009, 124:2460-2467.
13. Murata M., Narahara S., Umezaki K., Toita R., Tabata S., Piao J.S., Abe K., Kang J.H., Oouchida K., Cui L., Hashizume M. Liver cell specific targeting by the preS1 domain of hapatitis B virus surface antigen displayed on protein nanocages. Int. J. Nanomed. 2012, 7:4353-4362.
14. Seeger C., Mason W.S. Hepatitis B virus biology. Microbiol. Mol. Biol. Rev. 2000, 64:51-68.
15. Zhang X., Lin S.M., Chen T.Y., Liu M., Ye F., Chen Y.R., Shi L., He Y.L., Wu L.X., Zheng S.Q., Zhao Y.R., Zhang S.L. Asialoglycoprotein receptor interacts with the preS1 domain of hepatitis B virus in vivo and in vitro. Arch. Virol. 2011, 156:637-645.